BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37148381)

  • 1. Use of lymph node ratio to guide clinical decision-making concerning adjuvant radiotherapy in pT1-2N1 rectal cancer.
    Luo D; Ye Z; Zhang R; Li Q; Li X
    Int J Colorectal Dis; 2023 May; 38(1):115. PubMed ID: 37148381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma.
    Wang J; Liu Y; Shayan G; Ma Y; Yi J
    Radiother Oncol; 2022 Jul; 172():83-90. PubMed ID: 35568286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LODDS is superior to lymph node ratio for the prognosis of node-positive rectal cancer patients treated with preoperative radiotherapy.
    Huang B; Ni M; Chen C; Cai G; Cai S
    Tumori; 2017 Jan; 103(1):87-92. PubMed ID: 27716883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node ratio precisely predicts the benefit of postoperative radiotherapy in esophageal cancer: A retrospective cohort study.
    Liang Y; Jian Q; Deng MG; Yi Z; Peng C; Lu C; Yang H; Liu J
    Asian J Surg; 2023 Sep; 46(9):3680-3686. PubMed ID: 37059676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of lymph node ratio in patients with non-metastatic cervical cancer treated with radical hysterectomy: A population-based study.
    Ke Y; Zhang Z; Li Y; Qin Y; Yang Q; Zheng C
    Eur J Surg Oncol; 2024 Apr; 50(4):108258. PubMed ID: 38484490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of lymph node ratio in resectable rectal cancer after preoperative short-course radiotherapy-results from randomized clinical trial.
    Pach R; Szczepanik AM; Sierzega M; Daniluk M; Richter P
    Langenbecks Arch Surg; 2022 Nov; 407(7):2969-2980. PubMed ID: 35788774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic lymph node ratio can further stratify prognosis in rectal cancer patients treated with preoperative radiotherapy: a population-based analysis.
    Li QG; Li DW; Zhuo CH; Cai GX; Cai SJ
    Tumour Biol; 2014 Jul; 35(7):6389-95. PubMed ID: 24668545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of the Lymph Node Ratio in Surgical Patients With Distal Cholangiocarcinoma.
    Li X; Lin H; Sun Y; Gong J; Feng H; Tu J
    J Surg Res; 2019 Apr; 236():2-11. PubMed ID: 30694756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant therapy does not affect lymph node ratio in rectal cancer.
    Chang KH; Kelly NP; Duff GP; Condon ET; Waldron D; Coffey JC
    Surgeon; 2016 Oct; 14(5):270-3. PubMed ID: 26148760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Log odds of positive lymph nodes is a superior prognostic indicator in stage III rectal cancer patients: A retrospective analysis of 17,632 patients in the SEER database.
    Huang B; Chen C; Ni M; Mo S; Cai G; Cai S
    Int J Surg; 2016 Aug; 32():24-30. PubMed ID: 27321382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive lymph node ratio predicts adverse prognosis for patients with lymph nodes metastatic hypopharyngeal squamous cell carcinoma after primary surgery.
    Wang K; Tian W; Xu X; Peng X; Tang H; Zhao Y; Wang X; Li G
    Transl Cancer Res; 2022 Mar; 11(3):463-474. PubMed ID: 35402181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic value of lymph node ratio staging system in stage III( rectal cancer following 30 Gy/10 f preoperative radiotherapy].
    Wang L; Li Z; Li M; Peng Y; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Oct; 17(10):990-6. PubMed ID: 25341906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node ratio (LNR) as a complementary staging system to TNM staging in salivary gland cancer.
    Lei BW; Hu JQ; Yu PC; Wang YL; Wei WJ; Zhu J; Shi X; Qu N; Lu ZW; Ji QH
    Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3425-3434. PubMed ID: 31511971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of lymph node ratio in stage III non-small-cell lung cancer: A retrospective cohort study.
    Zhang X; Feng N; Wu B; Wei Y; Zhang W
    Medicine (Baltimore); 2023 Oct; 102(40):e35341. PubMed ID: 37800757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of lymph node ratio in comparison to positive lymph node count in penile squamous cell carcinoma.
    Yu J; Long Q; Zhang Z; Liao S; Zheng F
    Int Urol Nephrol; 2021 Dec; 53(12):2527-2540. PubMed ID: 34585313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis.
    Kai L; Zhoumiao C; Shaohua X; Zhao C; Zhijun L; Zhengfu H; Xiujun C
    J Cardiothorac Surg; 2021 Jan; 16(1):13. PubMed ID: 33468199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based study.
    Zhou J; He ZY; Li FY; Sun JY; Lin HX; Wu SG; Chen QH
    Oncotarget; 2016 Feb; 7(7):7952-9. PubMed ID: 26788911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy.
    Kim SI; Kim TH; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Kim JW; Park NH; Song YS
    Yonsei Med J; 2021 Mar; 62(3):231-239. PubMed ID: 33635013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node ratio and surgical quality are strong prognostic factors of rectal cancer: results from a single referral centre.
    Leonard D; Remue C; Abbes Orabi N; van Maanen A; Danse E; Dragean A; Debetancourt D; Humblet Y; Jouret-Mourin A; Maddalena F; Medina Benites A; Scalliet P; Sempoux C; Van den Eynde M; De Schoutheete JC; Kartheuser A
    Colorectal Dis; 2016 Jun; 18(6):O175-84. PubMed ID: 27128602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.